Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Reif

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Trends in Cell Biology|August 23, 2002
The CDM protein DOCK2 in lymphocyte migrationKarin Reif, Jason Cyster
The Journal of Pharmacology and Experimental Therapeutics|April 28, 2011
Antiarthritis effect of a novel Bruton's tyrosine kinase (BTK) inhibitor in rat collagen-induced arthritis and mechanism-based pharmacokinetic/pharmacodynamic modeling: relationships between inhibition of BTK phosphorylation and efficacyLichuan Liu, Julie Di Paolo, Jim Barbosa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2004
Cutting edge: differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homingKarin Reif, Klaus Okkenhaug, Takehiko Sasaki, et al.
Nature|March 8, 2002
Balanced responsiveness to chemoattractants from adjacent zones determines B-cell positionKarin Reif, Eric H Ekland, Lars Ohl, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 12, 2010
CD200R1 agonist attenuates mechanisms of chronic disease in a murine model of multiple sclerosisYingru Liu, Yoshio Bando, David Vargas-Lowy, et al.
Analytical Chemistry|November 1, 2016
Automated Affinity Capture and On-Tip Digestion to Accurately Quantitate in Vivo Deamidation of Therapeutic AntibodiesJohn C Tran, Daniel Tran, Amy Hilderbrand, et al.
Elife|July 21, 2025
Layilin regulates Treg motility and suppressive capacity in skinVictoire Gouirand, Sean Clancy, Courtney Macon, et al.
ACS Medicinal Chemistry Letters|August 25, 2020
Stereochemical Differences in Fluorocyclopropyl Amides Enable Tuning of Btk Inhibition and Off-Target ActivityJames J Crawford, Wendy Lee, Adam R Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2013
Identification of GNE-293, a potent and selective PI3Kδ inhibitor: navigating in vitro genotoxicity while improving potency and selectivityBrian S Safina, Zachary K Sweeney, Jun Li, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 23, 2016
Preclinical Safety Profile of a Depleting Antibody against CRTh2 for Asthma: Well Tolerated Despite Unexpected CRTh2 Expression on Vascular Pericytes in the Central Nervous System and Gastric MucosaKathila S Rajapaksa, Tao Huang, Neeraj Sharma, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Trends in Cell Biology|August 23, 2002
The CDM protein DOCK2 in lymphocyte migrationKarin Reif, Jason Cyster
The Journal of Pharmacology and Experimental Therapeutics|April 28, 2011
Antiarthritis effect of a novel Bruton's tyrosine kinase (BTK) inhibitor in rat collagen-induced arthritis and mechanism-based pharmacokinetic/pharmacodynamic modeling: relationships between inhibition of BTK phosphorylation and efficacyLichuan Liu, Julie Di Paolo, Jim Barbosa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2004
Cutting edge: differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homingKarin Reif, Klaus Okkenhaug, Takehiko Sasaki, et al.
Nature|March 8, 2002
Balanced responsiveness to chemoattractants from adjacent zones determines B-cell positionKarin Reif, Eric H Ekland, Lars Ohl, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 12, 2010
CD200R1 agonist attenuates mechanisms of chronic disease in a murine model of multiple sclerosisYingru Liu, Yoshio Bando, David Vargas-Lowy, et al.
Analytical Chemistry|November 1, 2016
Automated Affinity Capture and On-Tip Digestion to Accurately Quantitate in Vivo Deamidation of Therapeutic AntibodiesJohn C Tran, Daniel Tran, Amy Hilderbrand, et al.
Elife|July 21, 2025
Layilin regulates Treg motility and suppressive capacity in skinVictoire Gouirand, Sean Clancy, Courtney Macon, et al.
ACS Medicinal Chemistry Letters|August 25, 2020
Stereochemical Differences in Fluorocyclopropyl Amides Enable Tuning of Btk Inhibition and Off-Target ActivityJames J Crawford, Wendy Lee, Adam R Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2013
Identification of GNE-293, a potent and selective PI3Kδ inhibitor: navigating in vitro genotoxicity while improving potency and selectivityBrian S Safina, Zachary K Sweeney, Jun Li, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 23, 2016
Preclinical Safety Profile of a Depleting Antibody against CRTh2 for Asthma: Well Tolerated Despite Unexpected CRTh2 Expression on Vascular Pericytes in the Central Nervous System and Gastric MucosaKathila S Rajapaksa, Tao Huang, Neeraj Sharma, et al.
Pageof 2